Usability and Cost-of-Usability of Three Dry-Powder Inhalers (DPIs) in Patients with Chronic Obstructive Pulmonary Disease (COPD): May These Variables Influence the Health Technology Assessment of DPIs?

Health Technology Assessment ◽

Pulmonary Disease ◽

Technology Assessment ◽

Health Technology ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

PRS60 IMPACT of Health Technology Assessment (HTA) Recommendations on the Use of Fixed-Dose Combination (FDC) Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Value in Health ◽

10.1016/j.jval.2020.08.1940 ◽

2020 ◽

Vol 23 ◽

pp. S728

Author(s):

J. Cook ◽

J. Lewis ◽

Z. Marjenberg ◽

J. Hernando Platz ◽

S. Langham

Keyword(s):

Health Technology Assessment ◽

Triple Therapy ◽

Pulmonary Disease ◽

Technology Assessment ◽

Health Technology ◽

Fixed Dose ◽

Chronic Obstructive ◽

Dose Combination

Extrafine beclometasone dipropionate/formoterol fumarate metered-dose and dry-powder inhalers in asthma and chronic obstructive pulmonary disease: a profile of their use

Drugs & Therapy Perspectives ◽

10.1007/s40267-017-0397-7 ◽

2017 ◽

Vol 33 (6) ◽

pp. 260-271

Author(s):

Sohita Dhillon

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Metered Dose ◽

Formoterol Fumarate

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease

Journal of Market Access & Health Policy ◽

10.1080/20016689.2021.1929757 ◽

2021 ◽

Vol 9 (1) ◽

pp. 1929757

Author(s):

Jennifer Cook ◽

Chloe Bloom ◽

Jen Lewis ◽

Zoe Marjenberg ◽

Jaime Hernando Platz ◽

...

Keyword(s):

Health Technology Assessment ◽

Triple Therapy ◽

Technology Assessment ◽

Health Technology ◽

Prescribing Patterns ◽

Fixed Dose ◽

Chronic Obstructive ◽

Dose Combination

P226 Inhalation characteristics with spiromax®and turbuhaler®dry powder inhalers (dpi) in healthy adults and patients with asthma or chronic obstructive pulmonary disease (copd): before and after enhanced training: Abstract P226 Table 1.

Thorax ◽

10.1136/thoraxjnl-2013-204457.378 ◽

2013 ◽

Vol 68 (Suppl 3) ◽

pp. A178.2-A179 ◽

Cited By ~ 1

Author(s):

H Chrystyn ◽

W Azouz ◽

P Chetcuti ◽

H Hosker ◽

D Saralaya

Keyword(s):

Pulmonary Disease ◽

Healthy Adults ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Before And After

The Potential For Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Spain: Estimated Impact On Number And Cost Of Unscheduled Healthcare Events

Value in Health ◽

10.1016/j.jval.2015.09.638 ◽

2015 ◽

Vol 18 (7) ◽

pp. A350-A351 ◽

Cited By ~ 1

Author(s):

A Lewis ◽

M Blackney ◽

L Garcia Bujalance ◽

R Sánchez-de la Rosa ◽

S Torvinen ◽

...

Keyword(s):

Pulmonary Disease ◽

Inhalation Technique ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Formoterol Fumarate

Onset of Action of Formoterol versus Salmeterol via Dry Powder Inhalers in Moderate Chronic Obstructive Pulmonary Disease

Clinical Drug Investigation ◽

10.2165/11630880-000000000-00000 ◽

2012 ◽

Vol 32 (3) ◽

pp. 147-155 ◽

Cited By ~ 5

Author(s):

Mario Cazzola ◽

Pierluigi Paggiaro ◽

Paolo Palange ◽

Leif Bjermer ◽

Pilar Ausin ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Onset Of Action ◽

Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers

Journal of Aerosol Medicine and Pulmonary Drug Delivery ◽

10.1089/jamp.2017.1416 ◽

2017 ◽

Vol 30 (6) ◽

pp. 381-387 ◽

Cited By ~ 25

Author(s):

Sohini Ghosh ◽

Jill A. Ohar ◽

M. Bradley Drummond

Keyword(s):

Pulmonary Disease ◽

Flow Rate ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Inspiratory Flow Rate ◽

Dry Powder ◽

Peak Inspiratory Flow ◽

Peak Inspiratory Flow Rate

A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease

Expert Opinion on Drug Delivery ◽

10.1517/17425247.2013.817387 ◽

2013 ◽

Vol 10 (9) ◽

pp. 1171-1178 ◽

Cited By ~ 13

Author(s):

Job van der Palen ◽

Paul van der Valk ◽

Martijn Goosens ◽

Karin Groothuis-Oudshoorn ◽

Marjolein Brusse-Keizer

Keyword(s):

Pulmonary Disease ◽

Ease Of Use ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s298514 ◽

2021 ◽

Vol Volume 16 ◽

pp. 1193-1201

Author(s):

Rain Jõgi ◽

Leena Mattila ◽

Mikko Vahteristo ◽

Aino Takala ◽

Satu Lähelmä ◽

...

Keyword(s):

Healthy Volunteers ◽

Pulmonary Disease ◽

Inspiratory Flow ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Flow Parameters ◽

Device Resistance

The Budget Impact Of Duoresp® Spiromax® Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Italy: Estimated Impact Of Inhalation Technique

Value in Health ◽

10.1016/j.jval.2015.09.1391 ◽

2015 ◽

Vol 18 (7) ◽

pp. A496

Author(s):

S Torvinen ◽

J Nicolai ◽

S Pulimeno ◽

L di Nola ◽

GM Bruno ◽

...

Keyword(s):

Pulmonary Disease ◽

Budget Impact ◽

Inhalation Technique ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽